Special Issue "Inflammatory Bowel Diseases: New Diagnostic and Therapeutic Approaches"
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 537
2. Unit of Pharmacology and Therapeutics, Department of Biomedicine, Faculty of Medicine, University of Porto, Porto, Portugal
Interests: inflammatory bowel disease; endoscopy
Special Issues, Collections and Topics in MDPI journals
2. Unidade de Farmacologia Clínica, São João Hospital University Centre, Porto, Portugal
3. Unit of Pharmacology and Therapeutics, Department of Biomedicine, Faculty of Medicine, University of Porto, Porto, Portugal
Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are lifelong gastrointestinal tract disorders whose prevalence is projected to reach 1% by 2030. The unpredictable remitting–relapsing course is a defining characteristic, significantly contributing to the burden of IBD. Remarkable advancements in the understanding of IBDs have been made in recent decades. It is now evident that IBDs arise from a complex interplay of genetic, environmental, and microbial factors, leading to dysregulated immune responses. However, there are still several unresolved aspects that limit timely diagnosis and therapeutic options, impacting patients' prognosis and quality of life. Therefore, it is crucial to encourage research that addresses the existing knowledge gaps. In this Special Issue, we invite original research or review articles focused on various topics related to IBD, including:
- Mechanisms underlying IBD pathogenesis;
- Disease monitoring;
- Pharmacological innovations (new targets and combination therapy);
- Endoscopic treatment;
- Risk stratification and individualized therapy;
- Management of extraintestinal manifestations;
- Comorbidities in patients with IBD
Dr. Maria Manuela Estevinho
Dr. Fernando Magro
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- bowel inflammation
- crohn’s disease
- inflammatory bowel disease
- targeted therapy
- ulcerative colitis